Apr 24 |
Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Apr 10 |
Nuvation Bio Completes Acquisition of AnHeart Therapeutics
|
Mar 31 |
Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer Candidate
|
Mar 28 |
Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer
|
Mar 27 |
Nuvation Bio continues to surge as more upgrades follow after AnHeart deal
|
Mar 26 |
BTIG upgrades Nuvation to buy, cites AnHeart acquisition
|
Mar 26 |
Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
|
Mar 25 |
Nuvation Bio falls after AnHeart Therapeutics acquisition news
|
Mar 25 |
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
|
Mar 25 |
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
|